Jared Seehafer
- Co-Founder and CEO at Enzyme
GetLatka interview
How Enzyme Reached 21 Customers Helping Life Science Companies Navigate FDA Compliance (Interview with CEO Jared Seehafer)
Jared Seehafer (Co-Founder and CEO of Enzyme) spoke to Nathan Latka on December 3, 2018.
Enzyme figures from the interview
- Customers (2018)
- 21
- Team Size (2018)
- 8
- Total Funding Raised (2018)
- A couple million dollars
- Investor
- Y Combinator
“So we've got 21 companies that are using the platform in production of various sizes, everything from sort of product teams to the large organizations, enterprise organizations to, like I said, kind of a garage startup.”
“So we were in sort of quasi stealth, though I hate the term in 2017, launched the company earlier this year in 2018, Q1.”
“We went through Y Combinator Accelerator, did a small friends and family round, kind of just when I was just getting started. Then went through YC and then raised a seed stage round of capital, you know, through various VCs that are kind of in that, at that cohort right after YC.”
Bio
Jared Seehafer is the CEO and Cofounder of Enzyme, a software company that automates life science regulatory approval and compliance. He is a 12 year veteran of the medical device and biopharma industries, having worked or consulted at organizations ranging from Amgen, Abbott and Medtronic to seed-stage startups.
Company
Enzyme
South San Francisco, United States · Founded 2017
- Revenue
- $10.3M
- Funding
- $2M
- Team size
- 33
- Customers
- 21